Research Alliance Corp III (RACC) stock analysis
RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.12−0.03 (-0.30%)
Close on Nov 12, 2026Market cap $92.08MP/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Research Alliance Corp III.
See a number that looks wrong?